Skip to main content
Livermore
Livermore
ZHEN

Squarepoint Ops LLC

SEC CIK
0001642575
Latest filing
Aug 14, 2026

NKTR holding history

Nektar Therapeutics in every 13F filed by Squarepoint Ops LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NKTR overviewAll 13F holders of NKTRFull Q2 2026 holdings

Shares (Q2 2026)
5,807
Value
$405.4K
% of portfolio
<0.1%
Quarters held
16
Since Q1 2021
Holdings of NKTR by Squarepoint Ops LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20265,807$405.4K<0.1%−101,578−94.6%ReducedHolders
Q1 2026107,385$7.73M<0.1%+87,128+430.1%AddedHolders
Q4 202520,257$856.5K<0.1%−14,243−41.3%ReducedHolders
Q3 202534,500$1.96M<0.1%+34,500NewHolders
Q1 20250$00.0%−139,758−100.0%Sold outHolders
Q4 2024139,758$130.0K<0.1%+139,758NewHolders
Q2 20240$00.0%−38,781−100.0%Sold outHolders
Q1 202438,781$36.2K<0.1%−89,385−69.7%ReducedHolders
Q4 2023128,166$72.4K<0.1%+128,166NewHolders
Q3 20230$00.0%−814,799−100.0%Sold outHolders
Q2 2023814,799$468.7K<0.1%+134,285+19.7%AddedHolders
Q1 2023680,514$478.3K<0.1%+634,238+1,370.6%AddedHolders
Q4 202246,276$104.6K<0.1%−86,437−65.1%ReducedHolders
Q3 2022132,713$425.0K<0.1%+132,713NewHolders
Q2 20220$00.0%−144,226−100.0%Sold outHolders
Q1 2022144,226$777.0K<0.1%−16,403−10.2%ReducedHolders
Q4 2021160,629$2.17M<0.1%+148,754+1,252.7%AddedHolders
Q3 202111,875$213.0K<0.1%−76,626−86.6%ReducedHolders
Q2 202188,501$1.52M<0.1%+68,806+349.4%AddedHolders
Q1 202119,695$394.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.